Cargando…

Indoleamine 2,3-Dioxygenase Is Involved in Interferon Gamma’s Anti-BKPyV Activity in Renal Cells

Reactivation of BK polyomavirus (BKPyV) infection is frequently increasing in transplant recipients treated with potent immunosuppressants and highlights the importance of immune system components in controlling viral reactivation. However, the immune response to BKPyV in general and the role of ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fiore, Tony, Martin, Elodie, Descamps, Véronique, Brochot, Etienne, Morel, Virginie, Handala, Lynda, Dakroub, Fatima, Castelain, Sandrine, Duverlie, Gilles, Helle, François, François, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472348/ https://www.ncbi.nlm.nih.gov/pubmed/32784805 http://dx.doi.org/10.3390/v12080865

Ejemplares similares

Biology of the BKPyV: An Update
por: Helle, Francois, et al.
Publicado: (2017)

BK Polyomavirus Hijacks Extracellular Vesicles for En Bloc Transmission
por: Handala, Lynda, et al.
Publicado: (2020)

Comparison of different serological assays for SARS-CoV-2 in real life
por: Brochot, Etienne, et al.
Publicado: (2020)

Intercellular Transmission of Naked Viruses through Extracellular Vesicles: Focus on Polyomaviruses
por: Helle, Francois, et al.
Publicado: (2020)

1189. Correlation of BK polyomavirus (BKPyV)-specific Immunity and BKPyV Viruria within 6 months after Kidney Transplantation: A Prospective Cohort Study
por: Siripoon, Tanaya, et al.
Publicado: (2020)

Genotypes and Variants of BKPyV in Organ Donors after Brain Death
por: Furmaga, Jacek, et al.
Publicado: (2022)

Hepatitis C Virus Resistance to Carbohydrate-Binding Agents
por: Izquierdo, Laure, et al.
Publicado: (2016)

Discriminating between JCPyV and BKPyV in Urinary Virome Data Sets
por: Mormando, Rita, et al.
Publicado: (2021)

BK Polyomavirus Micro-RNAs: Time Course and Clinical Relevance in Kidney Transplant Recipients
por: Demey, Baptiste, et al.
Publicado: (2021)

Clinically Relevant Reactivation of Polyomavirus BK (BKPyV) in HLA-A02-Positive Renal Transplant Recipients Is Associated with Impaired Effector-Memory Differentiation of BKPyV-Specific CD8(+) T Cells
por: van Aalderen, Michiel C., et al.
Publicado: (2016)

Simeprevir for the treatment of hepatitis C virus infection
por: Izquierdo, Laure, et al.
Publicado: (2014)

BK Polyomavirus bkv-miR-B1-5p: A Stable Micro-RNA to Monitor Active Viral Replication after Kidney Transplantation
por: Demey, Baptiste, et al.
Publicado: (2022)

Longitudinal monitoring of BKPyV miRNA levels in kidney transplant recipients with BKPyV‐related pathology reflects viral DNA levels and remain high in viremia patients after clearance of viral DNA
por: van Doesum, Willem B., et al.
Publicado: (2022)

Specific and quantitative detection of Human polyomaviruses BKPyV and JCPyV in the healthy Pakistani population
por: Hussain, Iqra, et al.
Publicado: (2017)

Pretransplantation seroreactivity in kidney donors and recipients as a predictive factor for posttransplant BKPyV-DNAemia
por: Saláková, Martina, et al.
Publicado: (2022)

Longitudinal Analysis and Comparison of Six Serological Assays up to Eight Months Post-COVID-19 Diagnosis
por: Aubry, Aurélien, et al.
Publicado: (2021)

The role of the DE and EF loop of BKPyV VP1 in the serological cross-reactivity between subtypes
por: Hejtmánková, Alžběta, et al.
Publicado: (2022)

Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status
por: Helle, François, et al.
Publicado: (2022)

The differential presence of human polyomaviruses, JCPyV and BKPyV, in prostate cancer and benign prostate hypertrophy tissues
por: Shen, Chenghuang, et al.
Publicado: (2021)

Neurological Disease-Affected Patients, including Multiple Sclerosis, Are Poor Responders to BKPyV, a Human Polyomavirus
por: Bononi, Ilaria, et al.
Publicado: (2022)

Human polyomavirus BKPyV and JCPyV serostatus has no impact on women´s human papillomavirus infection outcome
por: Laine, Hanna K., et al.
Publicado: (2023)

Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles
por: Oliveira, Catarina, et al.
Publicado: (2017)

Permissivity of Primary Human Hepatocytes and Different Hepatoma Cell Lines to Cell Culture Adapted Hepatitis C Virus
por: Helle, Francois, et al.
Publicado: (2013)

Correction: Permissivity of Primary Human Hepatocytes and Different Hepatoma Cell Lines to Cell Culture Adapted Hepatitis C Virus
por: Helle, Francois, et al.
Publicado: (2019)

Specific Detection of Serum Antibodies against BKPyV, A Small DNA Tumour Virus, in Patients Affected by Choroidal Nevi
por: Pietrobon, Silvia, et al.
Publicado: (2017)

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
por: Brochot, Etienne, et al.
Publicado: (2020)

Enhanced anti-HCV activity of interferon alpha 17 subtype
por: Dubois, Aurelie, et al.
Publicado: (2009)

Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays
por: Demey, Baptiste, et al.
Publicado: (2020)

Alginate Hydrogel Protects Encapsulated Hepatic HuH-7 Cells against Hepatitis C Virus and Other Viral Infections
por: Tran, Nhu-Mai, et al.
Publicado: (2014)

Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer
por: Baker, Simon C., et al.
Publicado: (2022)

Coinfection with Epstein–Barr Virus (EBV), Human Papilloma Virus (HPV) and Polyoma BK Virus (BKPyV) in Laryngeal, Oropharyngeal and Oral Cavity Cancer
por: Drop, Bartłomiej, et al.
Publicado: (2017)

QuantIF: An ImageJ Macro to Automatically Determine the Percentage of Infected Cells after Immunofluorescence
por: Handala, Lynda, et al.
Publicado: (2019)

A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
por: Fournier, Carole, et al.
Publicado: (2007)

Epidemiology and seasonality of acute respiratory infections in hospitalized children over four consecutive years (2012–2016)
por: Fillatre, Adrien, et al.
Publicado: (2018)

Prevalence and viral loads of polyomaviruses BKPyV, JCPyV, MCPyV, TSPyV and NJPyV and hepatitis viruses HBV, HCV and HEV in HIV-infected patients in China
por: Zhou, Xianfeng, et al.
Publicado: (2020)

Interferon-γ Regulates the Proliferation and Differentiation of Mesenchymal Stem Cells via Activation of Indoleamine 2,3 Dioxygenase (IDO)
por: Croitoru-Lamoury, Juliana, et al.
Publicado: (2011)

Localization of Indoleamine 2,3-Dioxygenase-1 and Indoleamine 2,3-Dioxygenase-2 at the Human Maternal-Fetal Interface
por: Kudo, Yoshiki, et al.
Publicado: (2020)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
por: Brochez, Lieve, et al.
Publicado: (2021)

Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges
por: Peng, Xuerun, et al.
Publicado: (2022)

Detection Analysis and Study of Genomic Region Variability of JCPyV, BKPyV, MCPyV, HPyV6, HPyV7 and QPyV in the Urine and Plasma of HIV-1-Infected Patients
por: Passerini, Sara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ionunqh1omqhqk4va8k7m02v04